These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36250097)

  • 1.
    Chaudhary NS; Armstrong ND; Hidalgo BA; Gutiérrez OM; Hellwege JN; Limdi NA; Reynolds RJ; Judd SE; Nadkarni GN; Lange L; Winkler CA; Kopp JB; Arnett DK; Tiwari HK; Irvin MR
    Front Med (Lausanne); 2022; 9():971297. PubMed ID: 36250097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-gene interactions in APOL1-associated nephropathy.
    Divers J; Palmer ND; Lu L; Langefeld CD; Rocco MV; Hicks PJ; Murea M; Ma L; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2014 Mar; 29(3):587-94. PubMed ID: 24157943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOL1 Risk Variants Associated with Serum Albumin in a Population-Based Cohort Study.
    Chaudhary NS; Tiwari HK; Hidalgo BA; Limdi NA; Reynolds RJ; Cushman M; Zakai NA; Lange L; Judd SE; Winkler CA; Kopp JB; Gutiérrez OM; Irvin MR
    Am J Nephrol; 2022; 53(2-3):182-190. PubMed ID: 35100591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans.
    Guan M; Keaton JM; Dimitrov L; Hicks PJ; Xu J; Palmer ND; Ma L; Das SK; Chen YI; Coresh J; Fornage M; Franceschini N; Kramer H; Langefeld CD; Mychaleckyj JC; Parekh RS; Post WS; Rasmussen-Torvik LJ; Rich SS; Rotter JI; Sedor JR; Thornley-Brown D; Tin A; Wilson JG; Freedman BI; Bowden DW; Ng MCY;
    Hum Genomics; 2019 May; 13(1):21. PubMed ID: 31092297
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Young BA; Wilson JG; Reiner A; Kestenbaum B; Franceschini N; Bansal N; Correa A; Himmelfarb J; Katz R
    Kidney Med; 2021; 3(6):962-973.e1. PubMed ID: 34939005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Exome-wide Association Study for Type 2 Diabetes-Attributed End-Stage Kidney Disease in African Americans.
    Guan M; Keaton JM; Dimitrov L; Hicks PJ; Xu J; Palmer ND; Wilson JG; Freedman BI; Bowden DW; Ng MCY
    Kidney Int Rep; 2018 Jul; 3(4):867-878. PubMed ID: 29989002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of Chronic Kidney Disease Stages Across Ancestries: The PAGE Study.
    Lin BM; Nadkarni GN; Tao R; Graff M; Fornage M; Buyske S; Matise TC; Highland HM; Wilkens LR; Carlson CS; Park SL; Setiawan VW; Ambite JL; Heiss G; Boerwinkle E; Lin DY; Morris AP; Loos RJF; Kooperberg C; North KE; Wassel CL; Franceschini N
    Front Genet; 2019; 10():494. PubMed ID: 31178898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Patterns, Apolipoprotein L1 Risk Genotypes, and CKD Outcomes Among Black Adults in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.
    Ilori TO; Brooks MS; Desai PN; Cheung KL; Judd SE; Crews DC; Cushman M; Winkler CA; Shlipak MG; Kopp JB; Naik RP; Estrella MM; Gutiérrez OM; Kramer H
    Kidney Med; 2023 May; 5(5):100621. PubMed ID: 37229446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
    Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
    J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.
    Skorecki KL; Lee JH; Langefeld CD; Rosset S; Tzur S; Wasser WG; Shemer R; Hawkins GA; Divers J; Parekh RS; Li M; Sampson MG; Kretzler M; Pollak MR; Shah S; Blackler D; Nichols B; Wilmot M; Alper SL; Freedman BI; Friedman DJ
    Nephrol Dial Transplant; 2018 Feb; 33(2):323-330. PubMed ID: 28339911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
    Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
    Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
    Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variants of
    Hung RKY; Binns-Roemer E; Booth JW; Hilton R; Harber M; Santana-Suarez B; Campbell L; Fox J; Ustianowski A; Cosgrove C; Burns JE; Clarke A; Price DA; Chadwick D; Onyango D; Hamzah L; Bramham K; Sabin CA; Winkler CA; Post FA;
    Kidney Int Rep; 2022 Apr; 7(4):786-796. PubMed ID: 35497797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement factor H gene associations with end-stage kidney disease in African Americans.
    Bonomo JA; Palmer ND; Hicks PJ; Lea JP; Okusa MD; Langefeld CD; Bowden DW; Freedman BI
    Nephrol Dial Transplant; 2014 Jul; 29(7):1409-14. PubMed ID: 24586071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and ESKD Disparities in African Americans.
    Umeukeje EM; Young BA
    Am J Kidney Dis; 2019 Dec; 74(6):811-821. PubMed ID: 31606237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
    Tzur S; Rosset S; Skorecki K; Wasser WG
    Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African Americans.
    Guan M; Ma J; Keaton JM; Dimitrov L; Mudgal P; Stromberg M; Bonomo JA; Hicks PJ; Freedman BI; Bowden DW; Ng MC
    Hum Genet; 2016 Nov; 135(11):1251-1262. PubMed ID: 27461219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI; Langefeld CD; Lu L; Divers J; Comeau ME; Kopp JB; Winkler CA; Nelson GW; Johnson RC; Palmer ND; Hicks PJ; Bostrom MA; Cooke JN; McDonough CW; Bowden DW
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.